Abstract: A protein having human plasmin inhibiting activity, substantially equivalent reactivity with human plasmin to a human .alpha..sub.2 -plasmin inhibitor derived from plasma, a binding ability to human fibrin about 1/4 to about 1/3 of that of the human .alpha..sub.2 -plasmin inhibitor derived from plasma, and a molecular weight of about 50,000 to about 77,000.

Abstract: Compositions of high lubrication and light coloration are disclosed in which a selected class of resins and rubbers is blended with a specified cured polybutadiene product. The cured product results from crosslinking more than 10% of vinyl bonds in a butadiene polymer having a vinyl bond content of not less 20% by mol in terms of its monomer unit. Also disclosed are solid lubricants comprising a specified fluorinated cured polybutadiene and compositions containing the solid lubricant.

Abstract: Power supplying unit to be used for supplying power to such a load as the motor for driving a submerged pump that scoops liquid out of a tank storing low temperature liquid like LNG and so forth. The power supplying unit has a ceramic sleeve fixed to the flange, a penetrating conductor inserted into this ceramic sleeve, and the ceramic sleeve and the penetrating conductor are coupled air-tightly to each other inside the flange (inside the tank) sealed outside the flange with a bellows of semi-mountain construction in cross section. The bellows has an elasticity and is mounted, when the ceramic sleeve and the penetrating conductor are linearly expanded at the maximum temperature during practical or normal use, or at the temperature slightly higher than the said level. The bellows is mounted between the ceramic sleeve and the penetrating conductor in a state where it is displaced to its maximum length due to its self elasticity.

Abstract: A particulate polybutadiene crosslinked material is disclosed along with a process of making the same. The particulate material has a substantially spherical, uniformly shaped configuration and comprises at least part of its surface layer occupied by a reaction product of polybutadiene and a silicone compound.

Abstract: cDNA encoding a human .alpha..sub.2 -plasmin inhibitor precursor protein represented by an amino acid sequence from the -39th Met to the 452nd Lys in FIG. 1 of the accompanying drawings; an amino acid sequence of a human .alpha..sub.2 -plasmin inhibitor precursor represented by an amino acid sequence from the -39th Met to the 452nd Lys in FIG. 1 of the accompanying drawings; and genomic DNA encoding a human .alpha..sub.2 -plasmin inhibitor protein which is composed of exons II, III, IV, V, VI, VII, VIII, IX and X in FIG. 4 of the accompanying drawings, said exons being bonded to one another via introns.

Abstract: Lubricant compositions of high lubrication and light coloration characteristics are made up essentially of a selected mineral or synthetic oil and a selected polybutadiene. The polymeric component contains greater than 20% by mol of vinyl bonds in terms of its monomeric unit and has crosslinked more than 10% of the vinyl bond content.

Abstract: A magnetic recording medium comprising a non-magnetic support having provided thereon a magnetic layer comprising ferromagnetic fine powder uniformly dispersed in a binder, wherein the binder comprises at least one resin selected from the group consisting of a vinyl chloride resin and a urethane resin, said resin for the binder has a weight average molecular weight of about from 20,000 to 80,000 and contains a low molecular weight fraction having a weight average molecular weight of about 3,000 or less in an amount of about 3 wt. % or less based on the amount of the resin.

Abstract: Thermosetting polymers predominantly of a polybutadiene as a base polymer is disclosed, which polybutadiene is so configured as to have a vinyl content of not less than 40% by mol of the total monomer mol and a crosslink reactivity of at least 70% of the vinyl content. The cured polymer is ultrahighly resistant to heat and particularly applicable as an engineering plastics. Also disclosed is a process for producing the thermosetting polymer with the use of a specific initiator.

Abstract: The present invention provides a monoclonal antibody specific to a thrombin-binding substance (TM), hybridomas producing the monoclonal antibody, a purification process of TM featuring the use of the monoclonal antibody as an immunoadsorbent, as well as an immunoassay of TM featuring the use of the monoclonal antibody.

Abstract: An image recording apparatus having a lens unit and a mirror unit. The lens unit and the mirror unit are movably supported by a frame of the apparatus. A cam plate is provided at the lens unit, and a lever is in abutment with the cam plate. When the lens unit is moved in a direction, the cam plate is also moved, so that the lever is pivotally moved. The lever is abutted on the mirror unit. The pivotal motion of the lever, the mirror unit is also moved in another direction. The cam plate has a plurality of cam surfaces each defining respective copying magnifications.

Abstract: An image recording apparatus for recording an image corresponding to an original on a photosensitive recording medium by irradiating light onto the original and converging light from the original onto the photosensitive recording medium. The apparatus includes a lens unit vertically movably supported by the frame, a plurality of position setting holes arrayed in a vertical direction of the frame, position setting means provided on the lens unit and capable of being inserted into one of the position setting holes for fixing the lens unit to the frame, urging means provided on the lens unit for urging the position setting means toward the frame to project the position setting means, actuating means provided on the lens unit for actuating the position setting means so that the position setting means retracts and moves away from the frame against urging force of the urging means when electric current is supplied to the actuating means.

Abstract: Highly pure 3,3',4,4'-biphenyltetracarboxylic acid (BPTA) and dianhydride thereof (BPDA) are produced by heating crude BPTA to give BPDA, treating the BPDA with hot water to give highly pure BPTA, and in the case of highly pure BPDA, heat treating the pure BPTA to give highly pure BPDA.

Abstract: Thrombin-binding substances are obtained by fractionating human urine by ion-exchange chromatography, affinity chromatography using a thrombin-bound carrier, immune adsorption column chromatography, gel filtration, and/or molecular-weight fractionation. One of the substances has a molecular weight of 46,500.+-.6,000 in reduced condition and 39,000.+-.10,000 in unreduced condition by SDS PAGE and an isoelectric point at pH 5.0-5.3, while the other has a molecular weight of 40,000.+-.8,000 in reduced condition and 31,000.+-.10,000 in unreduced condition by SDS PAGE and an isoelectric point at pH 4.9-5.7. They have strong affinity to thrombin. They are capable of promoting the thrombin catalyzed activation of protein C and prolong clotting time. They are stable to denaturing agents (urea and sodium dodecylsulfate).

Abstract: Novel thrombin-binding substances (A) and (B) are disclosed. The thrombin-binding substances have the following characteristics:(a) molecular weight:Thrombin-binding substance (A):90,000-92,000 under reduced conditions55,000-58,000 under unreduced conditionsThrombin-binding substance (B):98,000-105,000 under reduced conditions60,000-65,000 under unreduced conditions(b) isoelectric point:Thrombin-binding substance (A): pH 6.0-6.8Thrombin-binding substance (B): pH 5.8-6.5(c) affinity: strong affinity to thrombin(d) activity:(1) capable of promoting the thrombin catalyzed activation of protein C(2) prolongs clotting time; and(e) stability: stable to denaturing agents (sodium dodecylsulfate and urea).The thrombin-binding substances are useful as a medicine for curing thrombosis.

Abstract: A monoclonal antibody which is specific to human protein C which has calcium bound at the gammacarboxyglutamic acid(Gla) domain and does not recognize human protein C which is not bound to calcium at the Gla domain. The monoclonal antibody is used in an immunoassay method for determining human protein C having a Gla domain and in a method for recovering human protein C having a Gal domain.

Abstract: A positive type photoresist material comprises a polymer having structural units each represented by the following formula (I) of; ##STR1## wherein each of R.sup.1, R.sup.2, R.sup.3 and R.sup.6 represents a hydrogen atom or a hydrocarbon residue having 1 to 12 carbon atoms, each or R.sup.4 and R.sup.5 represents a hydrogen atom, a hydroxyl group or a hydrocarbon residue having 1 to 12 carbon atoms and Z represents--CH.sub.2 --.sub.n which n indicates an integer of 0 to 4.

Abstract: An improved multifilament superconductor is fabricated by the method in which a tin rod or tin based alloy rod is clad with a copper based alloy tube, the thus obtained copper-clad rod is further clad with a niobium based alloy tube, and a copper material is applied as a stabilizer on an outer peripheral surface of the niobium based alloy tube to form a composite. This composite is then reduced and thermally treated at a temperature ranging from 640.degree. to 770.degree. C. to thereby form an Nb.sub.3 Sn superconductor composite with a filament tube therein. At least one of the copper based alloy tube and the niobium based alloy tube contains 0.1-5.0 at. % titanium, and in addition, the tin based alloy rod may contain 0.1-3.5 at. % titanium. The tin is contained in the copper-clad rod at weight % of about 25-85, preferably 30-80 weight %.

Abstract: Positive acting electron beam resist materials are described. The material comprises a polymer having fundamental units of the general formula ##STR1## in which R.sub.1, R.sub.2 and R.sub.3 independently represent hydrogen or a hydrocarbon group having from 1 to 6 carbon atoms, and R.sub.4 represents an organic residue having from 1 to 20 carbon atoms. The polymer may be used, as the resist material, as it is or by mixing with other type of resin.

Abstract: A novel thrombin-binding substance having the characteristics of (a) molecular weight: 47,000.+-.6,000 in reduced condition and 38,000.+-.6,000 in unreduced condition, (b) isoelectric point: pH 4.9-5.7, (c) affinity: strong affinity to thrombin, (d) activity: (1) capable of promoting the thrombin catalyzed activation of protein C, (2) prolongs clotting time; and (e) stability: stable to denaturing agents (urea sodium and dodecylsulfate), can be prepared from a human placenta by means of extraction, fractionation using ion exchange chromatography and affinity chromatography, and/or gel filtration, followed by electrophoresis. The substance is useful as a medicine for the treatment of thrombosis.

Abstract: A method of separating activated human protein C, which comprises bringing a mixture containing activated human protein C having a gamma-carboxyglutamic acid (Gla) domain in the presence of a calcium ion into contact with a fixed antibody comprising an insoluble carrier and fixed thereto an antibody to a complex of human protein C and a calcium ion bound to the Gla domain whereby the activated human protein C is captured by the fixed antibody in the form in which the calcium ion is bound to the Gla domain.